Support our DRIVE to end COVID-19
Drug Innovation Ventures at Emory (DRIVE)—a nonprofit biotechnology company founded to discover and develop antiviral drugs to anticipate and help end deadly pandemics and outbreaks caused by viruses—has the most promising potential antiviral therapeutic for coronavirus that can be taken as a pill, making it easy to disseminate, which is a critical aspect in containing the pandemic.
To date, our treatment has been proven successful in animal trials and we are moving into human testing. With your help, we can accelerate the process to get our antivirals rapidly and safely approved.
Time is of the essence, and we need emergency support in light of the COVID-19 outbreak.
Please support our battle to end the current coronavirus pandemic by making a gift to DRIVE Research for a Coronavirus Cure.
More about DRIVE
DRIVE focuses on what the world needs, not what makes the most money. As a nonprofit company owned by Emory University, DRIVE’s only mission is to develop antiviral drugs that save lives.
Your gift today will help end worldwide pandemics and viral threats, such as the novel coronavirus.